HOPEWELL, N.J., Aug. 11, 2025 /PRNewswire/ — ProBio, a leading contract development and manufacturing organization (CDMO) specializing in gene and cell therapy, today announced the launch of its cGMP Adeno-Associated Virus (AAV) manufacturing services at its 128,000 sq. ft….
